Comparison
Magnesium L-Threonate vs Thymosin Alpha-1
Side-by-side of Magnesium L-Threonate and Thymosin Alpha-1. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Magnesium L-Threonate
Magnesium l-threonate (Magtein) crosses the blood-brain barrier. Typical dose 1,500-2,000 mg. Sleep and cognitive trial data, side effects.
Thymosin Alpha-1
Thymosin alpha-1 peptide (Zadaxin, thymalfasin): 28-amino-acid TA1 immunomodulator. Dosing, T-cell effects, hepatitis B and HCV adjunct evidence.
Effects at a glance
Magnesium L-Threonate
- •Distinct magnesium salt designed for blood-brain barrier penetration; not a higher-quality systemic magnesium
- •Liu 2010 rodent study: elevated CSF magnesium ~15% and increased hippocampal synaptic density
- •Trial portfolio in humans is small and mostly Magtein-funded; cognitive effects are modest where reported
- •Typical dose 1500 to 2000 mg/day delivers only ~108 to 144 mg of elemental magnesium
- •GI tolerability comparable to other magnesium forms; loose stools in a minority at 2000 mg/day
- •Distinct from magnesium glycinate, which is the conventional sleep/anxiety/repletion form
Thymosin Alpha-1
- •28-amino-acid synthetic peptide identical to thymic-derived immunomodulator
- •Approved in over 35 countries as Zadaxin for hepatitis B, hepatitis C adjunct, and immune support
- •Not FDA approved in US; compounded by 503A/503B pharmacies for off-label immune support
- •Modulates T-cell maturation, NK activity, and Th1 polarization in immunocompromised states
- •Standard label dose: 1.6 mg subcutaneously twice weekly
- •Cleanest safety profile in the peptide class with hundreds of regulated trials behind it
Side-by-side
| Attribute | Magnesium L-Threonate | Thymosin Alpha-1 |
|---|---|---|
| Category | supplement | peptide |
| Also known as | Mg-T, MgT, Magtein, magnesium threonate | Talpha1, Ta1, Zadaxin, Thymalfasin |
| Half-life (hr) ↗ | 4 | 2 |
| Typical dose (mg) ↗ | 2000 | 1.6 |
| Dosing frequency | 1 to 3 times daily | 2x weekly |
| Routes | oral | subcutaneous, intramuscular |
| Onset (hr) | 1 | 24 |
| Peak (hr) | 2 | 168 |
| Molecular weight | 294.5 | 3108.32 |
| Molecular formula | C8H14MgO10 | C129H215N33O55 |
| Mechanism | Proposed to deliver magnesium across the blood-brain barrier more effectively than other oral salts via threonate-related transporters, raising CNS magnesium and modulating NMDA receptor function and synaptic plasticity. | Synthetic peptide modulator of innate and adaptive immunity. Promotes T-cell maturation and CD4/CD8 production, modulates Th1/Th2 balance, stimulates NK cell activity, and modulates TLR2/TLR9 signaling in dendritic cells. |
| Legal status | OTC dietary supplement | Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List |
| WADA status | allowed | unknown |
| DEA / Rx | OTC supplement (not scheduled) | Rx only via international approval or US compounding (no controlled-substance schedule) |
| Pregnancy | Standard magnesium safety; Mg-T-specific data limited | Not recommended; insufficient data |
| CAS | 778571-57-6 | 62304-98-7 |
| PubChem CID | 10691810 | 16130571 |
| Wikidata | Q27151568 | Q913854 |
Safety profile
Magnesium L-Threonate
Common side effects
- loose stools
- mild GI upset
- headache (rare)
- fatigue (rare)
Contraindications
- severe renal impairment (eGFR below 30)
- hypermagnesemia
- myasthenia gravis (high doses)
- concurrent IV magnesium therapy
Interactions
- tetracyclines and fluoroquinolones: magnesium chelation reduces antibiotic absorption; separate by 2 to 4 hours(moderate)
- bisphosphonates: reduced absorption; separate by 2 hours minimum(moderate)
- muscle relaxants and aminoglycosides: potentiated neuromuscular blockade at high doses(moderate)
- antihypertensives: additive blood pressure reduction at high doses(minor)
Thymosin Alpha-1
Common side effects
- mild injection-site irritation (rare)
- transient mild fatigue (rare)
- occasional headache (rare)
Contraindications
- pregnancy
- lactation
- active organ transplant rejection therapy
- systemic immunosuppression for autoimmune disease (relative)
- severe active autoimmune disease (caution)
Interactions
- interferon-alpha: additive immune effect; used clinically in approved combination protocols(minor)
- calcineurin inhibitors (cyclosporine, tacrolimus): theoretical destabilization of immunosuppression; avoid(major)
- antimetabolites (azathioprine, mycophenolate): theoretical destabilization of immunosuppression; avoid(major)
- vaccine administration: may augment vaccine response in elderly or immunocompromised; coordinate with clinician(minor)
Which Should You Take?
Magnesium L-Threonate comes out ahead for most readers on the criteria we weight: 2 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-B outcome catalogued. Thymosin Alpha-1 is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick Magnesium L-Threonate.
- → If your priority is sleep onset or sleep quality, pick Magnesium L-Threonate.
- → If your priority is immune support, pick Thymosin Alpha-1.
- → If your priority is post-training recovery, pick Thymosin Alpha-1.
Edge case: If you want to avoid Approved in 35+ countries as Zadaxin (hepatitis B, hepatitis C adjunct, immune support); not FDA approved in US; compounded by 503A/503B pharmacies for off-label use; not on WADA Prohibited List, Magnesium L-Threonate is the more accessible choice.
Default choice: Magnesium L-Threonate. Lower friction to source, and broader goal coverage. Reach for Thymosin Alpha-1 only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Magnesium L-Threonate and Thymosin Alpha-1?
Magnesium L-Threonate and Thymosin Alpha-1 differ in category (supplement vs peptide), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Magnesium L-Threonate or Thymosin Alpha-1?
Magnesium L-Threonate half-life is 4 hours; Thymosin Alpha-1 half-life is 2 hours.
Can you stack Magnesium L-Threonate with Thymosin Alpha-1?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper